Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT05047991 · UNKNOWN
Trial details
- NCT number
- NCT05047991
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-11-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.